NCT05097274
- Conditions
- ATM Gene Mutation, BRCA Mutation, CHEK2 Gene Mutation, +14 more
- Locations
-
- Cancer Genetics Unit, Royal Marsden Hospital London, Sutton, Surrey, United Kingdom
Clinical trial condition
CHEK2 Gene Mutation
Explore clinical trials studying CHEK2 Gene Mutation. Study availability and eligibility vary by location and protocol.
7 public trials
3 recruiting studies
CHEK2 Gene Mutation trial results
- Conditions
- APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06712095
- Conditions
- BMPR1A Gene Mutation, CDH1 Gene Mutation, CHEK2 Gene Mutation, +28 more
- Locations
-
- The Royal Marsden NHS Foundation Trust London, (Select), United Kingdom
Not Yet Recruiting
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
NCT07499999
- Conditions
- Adenocarcinoma, Ataxia Telangiectasia Mutated Gene Mutation, Atypical Lobular Hyperplasia, +16 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT03377556
- Conditions
- ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Olaparib In Metastatic Breast Cancer
NCT03344965
- Conditions
- ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Indiana University Indianapolis, Indiana, United States
Active, Not Recruiting
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092
- Conditions
- ATM Gene Mutation, Adenocarcinoma, BRCA Mutation, +20 more
- Locations
-
- E.O. Galliera Genoa, Italy
- Istituto Europeo di Oncologia Milan, Italy
- Istituto Nazionale Tumori G. Pascale Naples, Italy
- Istituto Oncologico Veneto Padova, Italy